• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Infectious Disease

Balancing vaccination rates with the lifting of lockdown restrictions may mitigate COVID-19 transmissibility

byNeel MistryandTeddy Guo
January 12, 2022
in Infectious Disease, Public Health
Reading Time: 2 mins read
Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children
Share on FacebookShare on TwitterShare on LinkedIn

1. According to the mathematical model, a one-month delay in lifting all restrictions may have decreased peak hospital admissions by three-fold.

2. Increased laxity in reopening can help to negate the negative impact of the delta variant.

Evidence Rating Level: 2 (Good)

Study Rundown: With the increase of vaccine availability in early 2021, the UK government designed a four-step out-of-lockdown policy for stepwise lifting of non-pharmaceutical interventions (NPIs) in March 2021. Sequentially, this included school reopening, outdoor hospitality and non-essential retail opening, indoor hospitality reopening, and lifting of all remaining restrictions. However, the emergence of the delta variant a few months after resulted in a rapid increase in COVID-19 cases. This mathematical modelling study aimed to assess the impact of the UK government’s four-step framework on easing lockdown restrictions in England, UK. Outcomes of interest included overall mortality and total number of hospital admissions. According to study results, there was significant uncertainty in determining the trajectory of the pandemic, given vaccine hesitancy and transmissibility of the delta variant. However, the stepwise reopening framework in tandem with increasing vaccination rates may have mitigated a substantial number of COVID-19 cases. In particular, a one-month delay of step four in the reopening policy, from June to July 2020, may have attenuated peak daily cases by three-fold. These findings suggest relaxation of lockdown restrictions should be balanced with rates of vaccine uptake, vaccine effectiveness, and potential variants of concern.

Click to read the study in The Lancet

Relevant Reading: Simulation-Based Estimation of SARS-CoV-2 Infections Associated With School Closures and Community-Based Nonpharmaceutical Interventions in Ontario, Canada

RELATED REPORTS

Chronic exposure to particulate matter is associated with increased cardiovascular risk

Lower levels of education and place of birth were associated with non-admission to the intensive care unit in Sweden during COVID-19 pandemic

Mortality in the post-housing period is high among homeless people in Ottawa, Canada

In-depth [retrospective cohort]: This mathematical model used factors such as hospital admissions, hospital occupancy, seroprevalence data, and population-level PCR testing to determine the trajectory of COVID-19 in England, according to various time frames of NPI relaxation. The first step of lifting restrictions began on March 8, 2021. The delta variant emerged in UK in April 2021, having a transmission advantage of 76% (95% credible interval [95% CrI] 69-83). Accordingly, step four of the framework, which was initially scheduled for June 20, 2021, was delayed by almost a month to July 19, 2021. The model predicted that lifting all remaining restrictions in June may have resulted in 3900 (95% CrI 1500-5700) peak daily hospital admissions. Instead, a delay in reopening reduced peak daily hospital admissions by three-fold to 1400 (95% CrI 700-1700). The current model was affected by transmission of delta variant and vaccine effectiveness. Overall, the proportion of active COVID-19 cases can be dramatically reduced by appropriate timing of NPI relaxation and continued vaccine rollout.

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: CoronavirusCOVID-19lockdown restrictionsmodeling studypredictive modelingpublic healthSARS-CoV-2vaccine uptake
Previous Post

Carbon ion radiotherapy for chordomas associated with similar oncologic outcomes and reduced adverse events compared to en bloc resection

Next Post

Wellness Check: Mental Health

RelatedReports

Cardiology

Chronic exposure to particulate matter is associated with increased cardiovascular risk

September 10, 2026
Novel coronavirus identified from patients with pneumonia in Wuhan, China
Emergency

Lower levels of education and place of birth were associated with non-admission to the intensive care unit in Sweden during COVID-19 pandemic

September 1, 2026
“Housing First” linked to housing stability for homeless youth with mental illness
Public Health

Mortality in the post-housing period is high among homeless people in Ottawa, Canada

August 31, 2026
Rivaroxaban likely reduces risk of recurrent stroke in specific subgroup of patients with embolic stroke of undetermined source
Weekly Rewinds

2 Minute Medicine Rewind August 31, 2026

August 31, 2026
Next Post

Wellness Check: Mental Health

#VisualAbstract: Arterial hyperoxia associated with mortality in critically ill children admitted to the pediatric intensive care unit

#VisualAbstract: Arterial hyperoxia associated with mortality in critically ill children admitted to the pediatric intensive care unit

#VisualAbstract: Moderate-dose hydroxyurea does not decrease stroke incidence but may lower hospitalization rates in children with sickle cell anaemia, compared to low-dose hydroxyurea

#VisualAbstract: Moderate-dose hydroxyurea does not decrease stroke incidence but may lower hospitalization rates in children with sickle cell anaemia, compared to low-dose hydroxyurea

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Children with intellectual and developmental disabilities have increased risks of depression and anxiety
  • Gabapentin (Neurontin) prescription for chronic low back pain in adults is associated with a higher risk of dementia
  • The rate of urethrocutaneous fistula formation may be similar between caudal and penile blocks
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.